Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |